![]() | Up a level |
(2022) Determination of a cost-effectiveness threshold for cancer interventions in Iran. Frontiers in Oncology. p. 9. ISSN 2234-943X
(2021) Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country. Value in Health Regional Issues. pp. 57-66.
(2021) Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer. pp. 130-136.
(2021) Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer. pp. 937-943.
(2020) Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services and Outcomes Research Methodology. pp. 183-194. ISSN 1387-3741